CST3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.063770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.240300E-02
Normal-vs-Stage2
1.323780E-01
Normal-vs-Stage3
2.603200E-01
Normal-vs-Stage4
4.962000E-02
Stage1-vs-Stage2
1.918410E-01
Stage1-vs-Stage3
4.498400E-01
Stage1-vs-Stage4
5.490000E-01
Stage2-vs-Stage3
9.402800E-01
Stage2-vs-Stage4
7.767600E-01
Stage3-vs-Stage4
7.863600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.181970E-01
Normal-vs-AfricanAmerican
1.257590E-01
Normal-vs-Asian
7.081800E-02
Caucasian-vs-AfricanAmerican
3.876200E-01
Caucasian-vs-Asian
1.121440E-01
AfricanAmerican-vs-Asian
8.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.290620E-01
Normal-vs-Female
8.470100E-02
Male-vs-Female
5.662800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.026600E-01
Normal-vs-Age(41-60Yrs)
7.803700E-02
Normal-vs-Age(61-80Yrs)
1.334390E-01
Normal-vs-Age(81-100Yrs)
1.418840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.502500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.056990E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.137200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.815000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.179800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.233580E-01
Normal-vs-Daily Drinker
1.041670E-03
Normal-vs-Weekly Drinker
1.310600E-01
Normal-vs-Occasional Drinker
2.753900E-02
Normal-vs-Social Drinker
2.299800E-01
Non Drinker-vs-Daily Drinker
2.126800E-01
Non Drinker-vs-Weekly Drinker
7.826800E-01
Non Drinker-vs-Occasional Drinker
3.918800E-01
Non Drinker-vs-Social Drinker
9.060600E-01
Daily Drinker-vs-Weekly Drinker
4.107800E-01
Daily Drinker-vs-Occasional Drinker
7.451500E-02
Daily Drinker-vs-Social Drinker
3.679400E-01
Weekly Drinker-vs-Occasional Drinker
3.753200E-01
Weekly Drinker-vs-Social Drinker
9.110600E-01
Occasional Drinker-vs-Social Drinker
5.246000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.217200E-01
Normal-vs-Grade 2
2.556000E-01
Normal-vs-Grade 3
6.966000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.808000E-01
Grade 1-vs-Grade 3
8.721500E-02
Grade 1-vs-Grade 4
4.217200E-01
Grade 2-vs-Grade 3
1.454630E-01
Grade 2-vs-Grade 4
2.556000E-01
Grade 3-vs-Grade 4
6.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.278200E-02
Normal-vs-NonDiabetic
1.251190E-01
Diabetic-vs-NonDiabetic
7.769400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.737500E-02
Normal-vs-NoPancreatitis
9.577900E-02
Pancreatitis-vs-NoPancreatitis
8.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.030000E-02
Normal-vs-N1
1.404750E-01
N0-vs-N1
4.827600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.474000E-01
Normal-vs-TP53-NonMutant
1.637180E-01
TP53-Mutant-vs-TP53-NonMutant
4.050000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
